40 ml of semaglutide The Indian government has approved #NovoNordisk's obesity drug, Wegovy, for the treatment #fattyliver disease. Novo Nordisk said the Central Drugs Standard Control Organisation (CDSCO) approved #Wegovy's 2.4 mg injection for Semaglutide Dosing: 250mcg/Week Protocol (2026)

Place a sterile cap on the bag

The short half-life of the No-DAC variant ensures GH pulses remain physiological and transient, reducing the risk of desensitization observed with long-term continuous GH exposure

Potential Implications: The peptides ability to enhance gene expression and promote healing across various tissues opens up possibilities for therapeutic applications in wound healing

The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Small Research Project under grant number (RGP1/132/46)

Who qualifies for GLP-1 weight loss injections